Daliresp (Roflumilast) — Patient-Friendly Guide (Australia)

Daliresp is a medicine containing roflumilast, used to help reduce flare-ups (exacerbations) in certain people with chronic lung disease, most commonly severe COPD (chronic obstructive pulmonary disease). This page explains how it works, how to take it, what to expect, and important safety information. It is written to be clear and patient-friendly for online pharmacy visitors in Australia.

Basic product information

• Medicine name: Daliresp
• Active ingredient: Roflumilast
• Medicine type: Anti-inflammatory medicine for airways (non-steroid)
• Common strength (varies by brand/formulation): Often 250 micrograms (mcg) and 500 mcg tablets are seen in markets
• Uses (main): Reducing COPD exacerbations in selected patients

Important: Daliresp is not a “rescue” medicine for sudden breathing problems. It is used for ongoing control and prevention strategies.

What Daliresp is used for (indications)

Daliresp (roflumilast) is mainly indicated for:

• Severe COPD associated with a history of exacerbations (flare-ups), particularly in people with chronic bronchitis symptoms.

It may be considered alongside inhaled maintenance therapies (such as long-acting bronchodilators and inhaled corticosteroids, when appropriate) as part of an overall COPD management plan.

How Daliresp works (mechanism of action)

Roflumilast belongs to a class of medicines called phosphodiesterase-4 (PDE4) inhibitors.

In COPD, inflammation and increased mucus production contribute to worsening symptoms. Roflumilast works by:

• Inhibiting PDE4, an enzyme involved in inflammatory signalling
• Reducing inflammatory mediators in the lungs
• Helping to lower airway inflammation, which can reduce exacerbation frequency in the right patients

Key point: Because it targets inflammation and prevents flare-ups, it is used for maintenance rather than immediate relief.

Pharmacokinetics: how the body handles roflumilast

Understanding how roflumilast is processed may help you anticipate how it behaves in the body.

Practical meaning: Effects on flare-up prevention may take time, so consistency matters. If you miss doses occasionally, it may not be immediately noticeable, but regular dosing helps.

Typical use and timing

Roflumilast is generally taken as a once-daily tablet. Many patients are advised to take it at the same time each day to maintain steady levels and make it easier to remember.

When will you notice benefits?

• Some people notice symptom and flare-up improvement over weeks.
• Because it prevents exacerbations, it may not feel like a “fast-acting” treatment.
• If you have concerns about how it’s working, review your COPD plan after an appropriate trial period.

How to take Daliresp

• Swallow the tablet with water.
• Try to take it at roughly the same time each day.
• Do not double up to make up for missed doses unless your clinician specifically advises this.

Food interactions: what to know

Food can influence the rate of absorption of roflumilast, though the overall exposure is generally not dramatically altered for many people.

General advice:

• You can usually take Daliresp with or without food, unless your clinician or the product information recommends otherwise.
• If you experience nausea or stomach discomfort, taking it with a meal may help some people.

Tip: Keep an eye on stomach-related side effects during the first few weeks and adjust how you take it (with or without food) if advised by your healthcare professional.

Alcohol and medicine interactions

Alcohol

There is no specific “absolute prohibition” on alcohol with roflumilast stated in many product monographs; however, caution is sensible because:

• Alcohol can worsen gastrointestinal symptoms (such as nausea or diarrhoea).
• Alcohol can worsen sleep and mood in some individuals, and roflumilast may affect neuropsychiatric symptoms in susceptible people.

Practical approach: If you drink alcohol, consider reducing your intake and discuss your individual risk factors with your healthcare professional.

Common medicine interactions (high-level)

Roflumilast is metabolised in the liver, so medicines that strongly affect liver enzymes may change its levels. Examples of interaction patterns include:

• Enzyme inducers may lower roflumilast exposure, potentially reducing benefit.
• Strong inhibitors may increase exposure, potentially increasing side effects.
• Other medicines that affect the liver may require closer monitoring.

Examples of relevant categories to mention to your clinician/pharmacist:

• Some treatments for epilepsy or other long-term conditions that can induce metabolism
• Some antibiotics/antifungals that influence metabolism
• Smoking status changes can influence some liver enzymes—if you smoke, tell your healthcare professional

Always check: Before starting, stopping, or changing any medicine, including herbal products and supplements, ask a pharmacist whether an interaction is possible with roflumilast.

Dosing: general guidance

Dosing may differ depending on individual factors, tolerability, and local product guidance.

• Typical starting approach: Many regimens start at a lower dose to improve tolerance, then may increase to a maintenance dose if needed.
• Maintenance dosing: Usually once daily at the chosen strength.

Do not adjust your dose without clinical advice. If you miss a dose, follow the instructions given with your medication or ask a pharmacist for advice.

Why dose adjustments happen: Common early side effects (such as nausea, diarrhoea, or weight loss) may influence dose decisions.

Safety profile and side effects

Like all medicines, Daliresp can cause side effects. Many people tolerate roflumilast reasonably, but it is important to know what to watch for.

Common side effects

• Diarrhoea
• Nausea
• Abdominal discomfort
• Headache
• Weight loss (can be clinically important in some people)
• Dizziness
• Reduced appetite

Serious or important risks (seek urgent medical advice)

• Worsening mood or depression: Seek advice promptly if you notice new or worsening depression, anxiety, or mood changes.
• Suicidal thoughts: If these occur, urgent help is needed immediately.
• Severe gastrointestinal symptoms: Persistent vomiting, severe diarrhoea, dehydration, or inability to keep fluids down should be assessed.
• Unexplained significant weight loss: Inform your clinician; weight monitoring may be recommended.
• Allergic reactions (rare): swelling of face/lips, rash with breathing difficulty, or collapse requires emergency care.

Who should take extra caution?

• People with a history of depression or significant mood disorders
• People who are underweight or at risk of weight loss
• People with significant gastrointestinal intolerance
• People with liver disease may need careful assessment and monitoring

Monitoring tips

• Track weight regularly (especially in the first months).
• Report persistent diarrhoea or nausea.
• Be alert for changes in mood, sleep, or behaviour.
• Keep COPD reviews as scheduled; response can vary between individuals.

Practical use tips to improve tolerance

If you experience side effects early on, it doesn’t necessarily mean you must stop—many issues can be managed with practical adjustments and clinical review.

• Take consistently each day (setting a phone reminder may help).
• Consider taking with food if nausea or stomach discomfort occurs.
• Hydrate well if diarrhoea occurs; manage dehydration promptly.
• Monitor appetite and weight; if you notice significant loss, speak to your clinician.
• Avoid abrupt changes to other COPD medicines unless advised.
• Don’t use it as rescue care for sudden breathlessness—use your recommended inhaler plan.

If side effects appear: contact your healthcare professional promptly. They may adjust the dose, review whether Daliresp is suitable, or offer supportive measures.

Alternative options for COPD prevention (overview)

There are different approaches to reducing COPD exacerbations. Alternatives depend on your COPD severity, symptoms, inhaler technique, smoking status, vaccination, and personal medical history.

Common alternative/adjunct strategies

• Inhaled bronchodilators (e.g., long-acting muscarinic antagonists and long-acting beta-agonists)
• Inhaled corticosteroids in selected patients, often based on exacerbation history and biomarkers
• Smoking cessation support (one of the most effective interventions)
• Pulmonary rehabilitation to improve function and symptom control
• Vaccinations (influenza, pneumococcal) to reduce infection-triggered exacerbations
• Oxygen therapy for those with chronic hypoxaemia (where indicated)
• In some cases, other anti-inflammatory or targeted therapies may be considered depending on phenotype

Note: Alternative options should be discussed with your clinician who knows your history and test results.

Market and legal context for Australia

In Australia, access to medicines such as roflumilast is governed by the Australian Therapeutic Goods Administration (TGA) and pharmacy supply regulations. Medicines are made available to patients through authorised channels that follow the applicable rules for safe supply and patient counselling.

What that means for you as a customer:

• Australian pharmacy products must meet regulatory standards for quality, safety, and labelling.
• Pharmacist counselling is commonly used to confirm suitability, identify interactions, and support safe use.

Availability can vary by supplier, pack size, and whether the medicine is widely stocked at the time of ordering.

Recent guidance and clinical updates (how to stay current)

Clinical guidance for COPD treatment can evolve over time, including recommendations around exacerbation prevention, inhaled therapy optimisation, non-pharmacological measures (such as pulmonary rehabilitation), and patient selection for medicines that target inflammatory pathways.

• Check that your COPD plan is updated with the latest local guidance from recognised Australian or international respiratory bodies.
• Ask your clinician or pharmacist whether your treatment remains appropriate based on your recent exacerbation history and current symptoms.
• If you experience frequent flare-ups, request a structured review of risk factors and treatment adherence.

Practical reminder: The “best” COPD regimen is individual—Daliresp is typically selected for certain people who have exacerbations despite standard inhaled maintenance approaches.

Delivery and availability (online pharmacy)

Online pharmacies in Australia commonly offer home delivery for medicines where permitted by law and where the supplier can dispense safely to the patient.

• Stock availability: Daliresp stock levels may vary; showing estimated dispatch times helps set expectations.
• Delivery times: Delivery can depend on location, transport networks, and courier schedules.
• Packaging: Medicines are usually shipped in protective packaging with clear labelling.

Tip: If you are about to run out, consider ordering ahead to avoid gaps in treatment. If you are switching strengths or brands, ensure you are taking the correct tablet strength as instructed.

Storage and handling

• Store tablets in a cool, dry place as directed on the packaging.
• Keep out of reach of children.
• Do not use tablets after the expiry date printed on the pack.

If you have questions about storage conditions for your specific pack, ask a pharmacist.

FAQ — Daliresp (Roflumilast)

1) Is Daliresp a reliever for sudden breathlessness?

No. Daliresp is not a rescue inhaler. It is used for long-term prevention of COPD exacerbations. For sudden symptoms, follow your prescribed action plan and use your approved reliever/rescue medication.

2) How long does roflumilast take to work?

Because its role is to reduce exacerbations and inflammation, benefits may develop over weeks. Your clinician may reassess the plan after an appropriate period based on your COPD severity and flare-up history.

3) Can I take Daliresp with food?

Often, yes. If you experience nausea or stomach discomfort, taking it with meals may improve tolerance. Follow the directions provided with your medication or by your healthcare professional.

4) What should I do if I miss a dose?

Follow the instructions on your medication label or product information. In general, do not double up. If you’re unsure, contact your pharmacist for personalised advice.

5) Does Daliresp cause weight loss?

Weight loss can occur and may be clinically important. If you notice significant or rapid weight changes, inform your clinician. Weight monitoring is commonly recommended.

6) Is Daliresp linked to mood changes?

Some people may experience mood-related side effects, including depression or anxiety. Seek prompt medical advice if you notice new or worsening mood symptoms, sleep disturbance, or behavioural changes.

7) Can I drink alcohol while taking Daliresp?

Moderate alcohol may be possible for some people, but alcohol can worsen gastrointestinal effects and may affect sleep and mood. Use caution and discuss your drinking habits with your pharmacist or clinician.

8) Are there medicines I should avoid?

Some medicines can affect how roflumilast is metabolised in the liver, potentially increasing side effects or reducing effectiveness. Provide your full list of medicines (including herbal products) to your pharmacist to check for interactions.

9) Who is Daliresp most suitable for?

It’s generally considered for people with severe COPD who have a history of exacerbations, especially with chronic bronchitis symptoms, and when used as part of a comprehensive COPD management plan.

10) What if I get diarrhoea or nausea?

Mild symptoms may improve as your body adjusts. Stay hydrated and consider taking the tablet with food if appropriate. If diarrhoea is severe, persistent, or you become dehydrated, seek medical advice promptly.

Summary

Daliresp (roflumilast) is a non-steroid anti-inflammatory medicine used to help reduce COPD exacerbations in selected patients. It works by inhibiting PDE4, helping to lower inflammatory signalling in the lungs. It is typically taken once daily, and many people need time to notice benefits.

To use Daliresp safely, pay attention to gastrointestinal symptoms, weight changes, and mood-related effects, and discuss any concerns early with your healthcare professional. If you have questions about suitability, interactions, or how to manage side effects, a pharmacist can help.